HLA-mismatched Microtransplantation for High Risk Acute Myeloid Leukemia

NCT01484171 · clinicaltrials.gov ↗

PHASE3

Phase

UNKNOWN

Status

50

Enrollment

OTHER

Sponsor class

Conditions

Acute Myeloid Leukemia

Interventions

DRUG: idarubicin
BIOLOGICAL: microtransplantation

Sponsor

The Affiliated Hospital of the Chinese Academy of Military Medical Sciences